Medicare Bill Contains Significant Changes for Drug Manufacturers

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-01-02-2004, Volume 28, Issue 1

The new Medicare bill affects pricing and coverage, revises payment formula, and clarifies generic patent issues.

Related Content:

Regulatory WatchPharmaceutical Technology-01-02-2004
Signing Off from Washington
Industry Challenges Medicare Price Negotiation Scheme
Drug Shortages Continue to Plague FDA and Manufacturers